These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27908443)

  • 41. Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
    van Riel SJ; Ciompi F; Winkler Wille MM; Dirksen A; Lam S; Scholten ET; Rossi SE; Sverzellati N; Naqibullah M; Wittenberg R; Hovinga-de Boer MC; Snoeren M; Peters-Bax L; Mets O; Brink M; Prokop M; Schaefer-Prokop C; van Ginneken B
    PLoS One; 2017; 12(11):e0185032. PubMed ID: 29121063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
    Winter A; Aberle DR; Hsu W
    Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment and validation of a prediction model for the probability of malignancy in solid solitary pulmonary nodules in northwest China.
    Duan XQ; Wang XL; Zhang LF; Liu XZ; Zhang WW; Liu YH; Dong CH; Zhao XH; Chen L
    J Surg Oncol; 2021 Mar; 123(4):1134-1143. PubMed ID: 33497476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary nodule malignancy probability: a diagnostic accuracy meta-analysis of the Mayo model.
    Papalampidou A; Papoutsi E; Katsaounou PA
    Clin Radiol; 2022 Jun; 77(6):443-450. PubMed ID: 35422255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant.
    Balekian AA; Silvestri GA; Simkovich SM; Mestaz PJ; Sanders GD; Daniel J; Porcel J; Gould MK
    Ann Am Thorac Soc; 2013 Dec; 10(6):629-35. PubMed ID: 24063427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and clinical application of deep learning model for lung nodules screening on CT images.
    Cui S; Ming S; Lin Y; Chen F; Shen Q; Li H; Chen G; Gong X; Wang H
    Sci Rep; 2020 Aug; 10(1):13657. PubMed ID: 32788705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter external validation of two malignancy risk prediction models in patients undergoing 18F-FDG-PET for solitary pulmonary nodule evaluation.
    Perandini S; Soardi GA; Larici AR; Del Ciello A; Rizzardi G; Solazzo A; Mancino L; Zeraj F; Bernhart M; Signorini M; Motton M; Montemezzi S
    Eur Radiol; 2017 May; 27(5):2042-2046. PubMed ID: 27631108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediastinal lymph nodes and pulmonary nodules in children: MDCT findings in a cohort of healthy subjects.
    Alves GR; Marchiori E; Irion KL; Guimarães MD; da Cunha CF; de Souza VV; Hochhegger B
    AJR Am J Roentgenol; 2015 Jan; 204(1):35-7. PubMed ID: 25539235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study.
    Gómez-Sáez N; González-Álvarez I; Vilar J; Hernández-Aguado I; Domingo ML; Lorente MF; Pastor-Valero M; Parker LA; Picazo N; Calbo J; Lumbreras B
    Eur Radiol; 2014 Sep; 24(9):2174-82. PubMed ID: 24962823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule.
    Mery CM; Pappas AN; Bueno R; Mentzer SJ; Lukanich JM; Sugarbaker DJ; Jaklitsch MT
    Chest; 2004 Jun; 125(6):2175-81. PubMed ID: 15189939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT.
    Venkadesh KV; Setio AAA; Schreuder A; Scholten ET; Chung K; W Wille MM; Saghir Z; van Ginneken B; Prokop M; Jacobs C
    Radiology; 2021 Aug; 300(2):438-447. PubMed ID: 34003056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
    Choi HK; Ghobrial M; Mazzone PJ
    Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
    Xu DM; van der Zaag-Loonen HJ; Oudkerk M; Wang Y; Vliegenthart R; Scholten ET; Verschakelen J; Prokop M; de Koning HJ; van Klaveren RJ
    Radiology; 2009 Jan; 250(1):264-72. PubMed ID: 18984780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation.
    Isbell JM; Deppen S; Putnam JB; Nesbitt JC; Lambright ES; Dawes A; Massion PP; Speroff T; Jones DR; Grogan EL
    Ann Thorac Surg; 2011 Jan; 91(1):227-33; discussion 233. PubMed ID: 21172518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung cancer prediction by Deep Learning to identify benign lung nodules.
    Heuvelmans MA; van Ooijen PMA; Ather S; Silva CF; Han D; Heussel CP; Hickes W; Kauczor HU; Novotny P; Peschl H; Rook M; Rubtsov R; von Stackelberg O; Tsakok MT; Arteta C; Declerck J; Kadir T; Pickup L; Gleeson F; Oudkerk M
    Lung Cancer; 2021 Apr; 154():1-4. PubMed ID: 33556604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging.
    Chandarana H; Heacock L; Rakheja R; DeMello LR; Bonavita J; Block TK; Geppert C; Babb JS; Friedman KP
    Radiology; 2013 Sep; 268(3):874-81. PubMed ID: 23737537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population.
    Chung K; Mets OM; Gerke PK; Jacobs C; den Harder AM; Scholten ET; Prokop M; de Jong PA; van Ginneken B; Schaefer-Prokop CM
    Thorax; 2018 Sep; 73(9):857-863. PubMed ID: 29777062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A weighted rule based method for predicting malignancy of pulmonary nodules by nodule characteristics.
    Kaya A; Can AB
    J Biomed Inform; 2015 Aug; 56():69-79. PubMed ID: 26008877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.